ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 38 filers reported holding ACER THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $449 | -99.8% | 179 | 0.0% | 0.00% | – |
| Q3 2022 | $249,000 | +10.2% | 179 | 0.0% | 0.00% | – |
| Q2 2022 | $226,000 | -56.5% | 179 | 0.0% | 0.00% | – |
| Q1 2022 | $519,000 | +26.0% | 179 | 0.0% | 0.00% | – |
| Q4 2021 | $412,000 | -9.6% | 179 | 0.0% | 0.00% | – |
| Q3 2021 | $456,000 | -10.9% | 179 | 0.0% | 0.00% | – |
| Q2 2021 | $512,000 | -8.1% | 179 | 0.0% | 0.00% | – |
| Q1 2021 | $557,000 | +18.8% | 179 | 0.0% | 0.00% | – |
| Q4 2020 | $469,000 | -9.1% | 179 | 0.0% | 0.00% | – |
| Q3 2020 | $516,000 | -98.5% | 179 | -98.2% | 0.00% | – |
| Q2 2020 | $34,746,000 | +1025.9% | 10,130 | +553.1% | 0.00% | – |
| Q1 2020 | $3,086,000 | +9.9% | 1,551 | +121.6% | 0.00% | – |
| Q4 2019 | $2,807,000 | +254.9% | 700 | +182.3% | 0.00% | – |
| Q3 2019 | $791,000 | +1451.0% | 248 | +1807.7% | 0.00% | – |
| Q2 2019 | $51,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 143,000 | $2,877,000 | 2.19% |
| Vivo Capital, LLC | 579,051 | $11,651,000 | 1.49% |
| Nantahala Capital Management | 903,455 | $18,178,000 | 0.56% |
| HEARTLAND ADVISORS INC | 220,000 | $4,426,000 | 0.37% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 388,712 | $7,821,000 | 0.34% |
| Avoro Capital Advisors LLC | 150,000 | $3,018,000 | 0.18% |
| Monashee Investment Management LLC | 11,364 | $229,000 | 0.16% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 125,000 | $2,515,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 20,000 | $402,000 | 0.10% |
| 683 Capital Management, LLC | 19,367 | $390,000 | 0.02% |